Excellence in monoclonal antibody and immunoassay development

Focus on...

Discover Diaclone

With over 30 years of experience and expertise, high quality has become the hallmark of the Diaclone Immunology products, firmly establishing us as a centre of excellence in Monoclonal Antibody research and Immunoassay Kit development.

Our experience and expertise coupled to the diversity and quality of our product range makes Diaclone a clear choice to Fast Track Your Research.

The expanding range of Diaclone immunology products is specifically designed for key research in clinical and preclinical applications by the pharmaceutical industry, biotechnology and diagnostic companies but also by public research laboratories in France and internationally.

Product types

Monoclonal Antibodies: unconjugated, labelled or azide free formats.

Immunoassays ELISA and ELISpot: pair, set and kit formats, ELISpot mono or dual

Recombinant proteins: Human Interleukins, SARS-CoV-2 and other targets under development

Standard catalogue and bulk sizes on request

The major research fields

Immunotherapy & Cancer - Vaccinology - Inflammation - Allergy - Autoimmune diseases - Apoptosis ...

The main applications

CD markers, Cytokine and Growth factors, TRAIL receptors, Cell adhesion molecules (CAM), In vivo controls, T-Cells…

A large range of specificities

Interleukins e.g. IL-2, IL-6, IL-8, IL-17 family…, CD markers e.g. CD138 (Syndecan), CD126…, IFN gamma, TNF alpha, Perforin, Granzyme, Isotype controls…

Target species: human, murine, rat, porcine…

The Diaclone service

Products developed in our own  laboratories by experts in immunology, for a high-quality service, deliveries within 48 hours, and direct  technical and scientific assistance

Diaclone is based in Besançon, France and is a member of the mAbexperts group (Biotech Investissement holding), a group of companies who collectively provide an expert synergy in the field of monoclonal antibodies, with highly experimented teams of researchers in their laboratories.



Now available - SARS-CoV-2 Spike RBD Variant Delta

Publication date : 2021-07-27
Developed in our laboratories in Besançon (France) #715-H25-0BU SARS-CoV-2 Spike RBD Variant Delta Lineage B.1.617.2

More info...


Medix Biochemica expands its monoclonal antibody offering through the acquisition of Diaclone

Publication date : 2021-07-13
Medix Biochemica has acquired 100 percent of the shares of Diaclone, a prominent provider of monoclonal antibodies in the areas of inflammation, oncology and immunology.

More info...